Detailed answers about INTERNATIONAL BIOMEDICAL ENGINEERING LTD, including incorporation, status, business activity, and accounts information.
When was INTERNATIONAL BIOMEDICAL ENGINEERING LTD founded?
INTERNATIONAL BIOMEDICAL ENGINEERING LTD was officially incorporated on 27 May 2025 and is registered under company number 16476760. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INTERNATIONAL BIOMEDICAL ENGINEERING LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INTERNATIONAL BIOMEDICAL ENGINEERING LTD?
INTERNATIONAL BIOMEDICAL ENGINEERING LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INTERNATIONAL BIOMEDICAL ENGINEERING LTD do?
INTERNATIONAL BIOMEDICAL ENGINEERING LTD operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is INTERNATIONAL BIOMEDICAL ENGINEERING LTD's registered address?
The registered office address of INTERNATIONAL BIOMEDICAL ENGINEERING LTD is 3RD FLOOR, 86-90, PAUL STREET, LONDON, ENGLAND, UNITED KINGDOM, EC2A 4NE. This is the official address filed with Companies House for legal and statutory correspondence.
Is INTERNATIONAL BIOMEDICAL ENGINEERING LTD financially stable?
Financial accounts for INTERNATIONAL BIOMEDICAL ENGINEERING LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.